News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
755,791 Results
Type
Article (45897)
Company Profile (304)
Press Release (709568)
Multimedia
Podcasts (106)
Webinars (26)
Section
Business (210142)
Career Advice (2128)
Deals (36228)
Drug Delivery (137)
Drug Development (84228)
Employer Resources (177)
FDA (17130)
Job Trends (15425)
News (356542)
Policy (33956)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (4)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2784)
Accelerated approval (47)
Adcomms (31)
Allergies (179)
Alliances (51357)
ALS (220)
Alzheimer's disease (1868)
Antibody-drug conjugate (ADC) (465)
Approvals (17496)
Artificial intelligence (717)
Autoimmune disease (304)
Automation (58)
Bankruptcy (369)
Best Places to Work (11932)
BIOSECURE Act (21)
Biosimilars (230)
Biotechnology (192)
Bladder cancer (201)
Brain cancer (76)
Breast cancer (769)
Cancer (6006)
Cardiovascular disease (494)
Career advice (1813)
Career pathing (45)
CAR-T (347)
CDC (60)
Celiac Disease (3)
Cell therapy (950)
Cervical cancer (47)
Clinical research (72953)
Collaboration (2165)
Company closure (7)
Compensation (1420)
Complete response letters (90)
COVID-19 (2867)
CRISPR (115)
C-suite (1170)
Cystic fibrosis (158)
Data (8050)
Decentralized trials (3)
Denatured (33)
Depression (177)
Dermatology (88)
Diabetes (608)
Diagnostics (7155)
Digital health (57)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (339)
Drug pricing (203)
Drug shortages (32)
Duchenne muscular dystrophy (292)
Earnings (93072)
Editorial (71)
Employer branding (23)
Employer resources (157)
Events (123565)
Executive appointments (1116)
FDA (20982)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1799)
Gene editing (248)
Generative AI (64)
Gene therapy (770)
GLP-1 (1114)
Government (4910)
Grass and pollen (7)
Guidances (409)
Healthcare (19638)
HIV (84)
Huntington's disease (60)
IgA nephropathy (101)
Immunology and inflammation (310)
Immuno-oncology (98)
Indications (194)
Infectious disease (3220)
Inflammatory bowel disease (227)
Inflation Reduction Act (14)
Influenza (140)
Intellectual property (298)
Interviews (336)
IPO (16913)
IRA (50)
Job creations (3810)
Job search strategy (1503)
JPM (60)
Kidney cancer (20)
Labor market (100)
Layoffs (595)
Leadership (43)
Legal (8197)
Liver cancer (103)
Longevity (34)
Lung cancer (785)
Lymphoma (435)
Machine learning (62)
Management (60)
Manufacturing (1074)
MASH (194)
Medical device (14565)
Medtech (14692)
Mergers & acquisitions (20565)
Metabolic disorders (1563)
mRNA (225)
Multiple sclerosis (194)
NASH (19)
Neurodegenerative disease (443)
Neuropsychiatric disorders (112)
Neuroscience (3447)
Neurotech (1)
NextGen: Class of 2026 (6774)
Non-profit (4744)
Now hiring (78)
Obesity (732)
Opinion (299)
Ovarian cancer (226)
Pain (269)
Pancreatic cancer (313)
Parkinson's disease (373)
Partnered (34)
Patents (605)
Patient recruitment (697)
Peanut (66)
People (61661)
Pharmaceutical (68)
Pharmacy benefit managers (32)
Phase 1 (22796)
Phase 2 (32127)
Phase 3 (23895)
Pipeline (8935)
Policy (332)
Postmarket research (2646)
Preclinical (9734)
Press Release (68)
Prostate cancer (310)
Psychedelics (61)
Radiopharmaceuticals (335)
Rare diseases (1141)
Real estate (6232)
Recruiting (72)
Regulatory (26418)
Reports (56)
Research institute (2584)
Resumes & cover letters (363)
Rett syndrome (40)
RNA editing (25)
RSV (90)
Schizophrenia (180)
Series A (308)
Series B (225)
Service/supplier (11)
Sickle cell disease (118)
Special edition (26)
Spinal muscular atrophy (172)
Sponsored (50)
Startups (3799)
State (2)
Stomach cancer (19)
Supply chain (130)
Tariffs (88)
The Weekly (70)
Vaccines (1154)
Venture capital (114)
Weight loss (479)
Women's health (131)
Worklife (20)
Date
Today (166)
Last 7 days (927)
Last 30 days (3609)
Last 365 days (31170)
2026 (13011)
2025 (31090)
2024 (36172)
2023 (41078)
2022 (52366)
2021 (56935)
2020 (55465)
2019 (48262)
2018 (36463)
2017 (33363)
2016 (32948)
2015 (38935)
2014 (32624)
2013 (27607)
2012 (29732)
2011 (30433)
2010 (28407)
Location
Africa (797)
Alabama (95)
Alaska (7)
Arizona (359)
Arkansas (15)
Asia (41382)
Australia (6862)
California (13534)
Canada (3809)
China (1382)
Colorado (577)
Connecticut (591)
Delaware (412)
Europe (92093)
Florida (2006)
Georgia (437)
Hawaii (4)
Idaho (62)
Illinois (1077)
India (92)
Indiana (614)
Iowa (24)
Japan (547)
Kansas (134)
Kentucky (51)
Louisiana (43)
Maine (88)
Maryland (1627)
Massachusetts (9753)
Michigan (368)
Minnesota (743)
Mississippi (7)
Missouri (148)
Montana (36)
Nebraska (29)
Nevada (146)
New Hampshire (86)
New Jersey (3544)
New Mexico (31)
New York (3560)
North Carolina (1760)
North Dakota (11)
Northern California (6763)
Ohio (408)
Oklahoma (25)
Oregon (45)
Pennsylvania (2720)
Puerto Rico (30)
Rhode Island (51)
South America (1166)
South Carolina (86)
South Dakota (2)
Southern California (5339)
Tennessee (217)
Texas (2156)
United States (47923)
Utah (405)
Vermont (1)
Virginia (338)
Washington D.C. (83)
Washington State (1083)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
755,791 Results for "alfa scientific designs inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immutep Receives FDA Orphan Drug Designation for Eftilagimod Alfa in Soft Tissue Sarcoma
April 15, 2026
·
3 min read
Press Releases
New Nature Communications Publication Highlights Efsubaglutide Alfa’s Effects on Glycaemia and β-Cell Function
May 13, 2026
·
2 min read
Press Releases
Orsini Selected as the Exclusive Specialty Pharmacy and Home Infusion Partner for Denali Therapeutics’ AVLAYAH™ (tividenofusp alfa-eknm)
April 20, 2026
·
2 min read
Press Releases
Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
May 18, 2026
·
10 min read
Press Releases
Press Release: Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema
December 17, 2025
·
6 min read
Press Releases
Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II)
March 25, 2026
·
17 min read
Press Releases
Marengo Reports Late-Breaking Initial Phase 2 Clinical Results from Invikafusp Alfa Plus TRODELVY® and Unveils Partnered Novel IPN01203/STAR0501 STAR Program in Phase 1 at AACR 2026
April 17, 2026
·
6 min read
Press Releases
Denali Therapeutics Announces Key Anticipated Milestones and Priorities for 2026 Including Commercial Launch of Tividenofusp Alfa for Hunter Syndrome
January 6, 2026
·
10 min read
Press Releases
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa)
March 9, 2026
·
13 min read
Press Releases
Milestone Scientific Inc. Completes $2.15 Million Private Placement
April 21, 2026
·
4 min read
1 of 75,580
Next
